• SENSEX 74,459.53
    308.49 (+0.42%)
  • BANKNIFTY 54,909.65
    642.25 (+1.18%)
  • Jio Platforms
    1,438.95 1,490.00(%)
  • NSE
    1,775.20 1,640.25(%)
  • Dalmia BharatLtd
    1,320.00 1,403.50(%)
  • Anand Rathi Wea.
    2,246.45 1,354.00(%)
  • Ather Energy
    1,782.05 1,741.90(%)
  • Reliance Industries
    1,152.50 1,152.30(%)
  • Laurus Labs
    2,392.00 2,245.00(%)
  • Sagility
    41.79 35.82(%)
  • UltraTech Cem.
    11,005.00 10,329.00(%)
  • Tonbo Imaging
    1,330.00 1,343.80(%)
  • Indian Hotels Co
    824.00 816.00(%)
  • Trent
    3,059.00 3,399.75(%)
  • HDFC Bank
    695.50 1,017.90(%)
  • ICICI AMC
    2,688.00 2,528.90(%)
  • Hexaware Tech.
    497.95 400.35(%)
  • Suzlon Energy
    33.21 36.30(%)
  • Godrej Consumer
    777.65 810.35(%)
  • Diamond Power
    350.00 406.80(%)
  • Equitas Sma. Fin
    47.26 51.30(%)
  • APL Apollo Tubes
    2,161.00 1,691.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Deep Health AI India Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 13584.0
  • ISIN : INE005G01026
1.58 0 (-1.25%)
  • As on 30 Oct 2026 (EOD)

  • Today’s Low

    1.55

  • Today’s High

    1.60

  • Open

    1.58

  • Perv Close

    1.60

  • 52W Low

    1.48

  • 52W High

    10.29

Key Indicators

  • P/E(TTM)

    4.51

  • Mar.Cap (₹Cr.)

    22.78

  • Div & Yield %

    6.33

  • Book Value(₹)

    3.58

  • Debt-Equity Ratio

    -1.25

  • AGM Date

    29-Oct-2026

  • EPS

    0.35

  • P/E Ratio

    4.51

Financials Ratios

  • Debt-Equity Ratio

    0.08

  • Mar.Cap (₹Cr.)

    22.78

  • RONW (%)

    2.06

  • ROCE (%)

    3.71

Score Board

  • Equity (₹ in Cr.)

    14.42

  • BV (₹)

    3.60

  • Sales( ₹ in Cr.)

    4.25

  • NP (in Cr.)

    3.32

  • NP Var(%)

    288.0

  • Div%

    10.0

  • CPS (₹)

    0.20

  • EPS (₹)

    0.20

  • Traded Value (₹ in Lakhs)

    22.78

  • 52 Week High

    10.29

  • 52 Week Low

    1.48

  • Price BSE

    2.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    22.78

  • P/C Ratio

    8.70

  • P/E Ratio

    8.70

  • Price Vs.BV

    0.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 4.25 1.26 2.56 7.67 1.39 0.51
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 4.25 1.26 2.56 7.67 1.39 0.51
Other Income 4.24 0.75 1.09 0.25 0.26 0.26
Stock Adjustments 0.00 -0.15 -0.40 -1.34 -0.81 0.04
Total Income 8.49 1.86 3.25 6.58 0.84 0.81
EXPENDITURE :            
Raw Materials 0.00 0.00 0.51 3.13 0.13 0.41
Power and Fuel Cost 0.01 0.00 0.01 0.00 0.00 0.00
Employee Cost 0.08 0.06 0.18 0.14 0.19 0.19
Other Manufacturing Expenses 0.00 0.00 0.00 0.00 0.03 0.02
Selling and Administration Expenses 0.82 0.58 0.64 1.41 0.21 0.13
Miscellaneous Expenses 5.78 0.01 1.07 0.03 0.02 0.03
Employee Benefit Expenses 0.08 0.06 0.18 0.14 0.19 0.19
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 6.69 0.66 2.41 4.71 0.58 0.77
Operating Profit 1.80 1.20 0.85 1.87 0.27 0.03
Interest 0.03 0.09 0.26 0.13 0.00 0.00
Gross Profit 1.77 1.11 0.59 1.74 0.27 0.03
Depreciation 0.01 0.01 0.01 0.01 0.00 0.02
Profit Before Tax 1.76 1.10 0.58 1.73 0.27 0.01
Current Tax 0.46 0.24 0.16 0.48 0.07 0.05
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit 1.30 0.86 0.42 1.26 0.20 -0.05
Extraordinary Items -2.02 0.01 0.01 -0.01 0.02 -0.01
Adjusted Net Profit 3.32 0.85 0.41 1.27 0.18 -0.04
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 6.76 5.90 5.48 4.22 4.02 4.07
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1.44 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 6.61 6.76 5.90 5.48 4.22 4.02
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.10 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.09 0.18 0.09 0.26 0.62 -0.15
Earnings Per Share(Adj)-Unit Curr 0.09 0.17 0.08 0.24 0.06 -0.01
Book Value 3.58 4.65 4.25 3.07 23.99 23.39
Book Value(Adj)-Unit Curr 3.58 4.30 3.93 2.83 2.22 2.16

Shareholding Pattern

  • Promoter Group

    0.03%

  • Public Share Holding

    99.97%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 40,330 0.03 40,330 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 40,330 0.03 40,330 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 1,000 0.00 1,000 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 500,000 0.35 500,000 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 501,000 0.35 501,000 2
2] Non Institution
Bodies Corporate 314,316 0.22 306,316 26
Clearing Members 12,002 0.01 12,002 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,182,850 0.82 822,850 142
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,111,258 0.77 1,111,258 245
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 9,006,674 6.25 9,006,674 28
Individuals holding nominal share capital up to Rs. 1 lakh 131,876,460 91.49 130,930,460 88,471
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 3,834 0.00 3,834 1
Others 0 0.00 0 0
Sub Total 143,608,670 99.62 142,294,670 88,918
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 144,150,000 100.00 142,836,000 88,930

Company Background

Deep Health AI India LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Deep Health AI India Ltd
  • BSE Code : 13584.0
  • ISIN : INE005G01026

  • Incorporation Year

    1994

  • Registered Office

    506-509 5th Floor Apeksha
    Plot No 256 Main Rd HiranMogri, Udaipur,
    Rajasthan-400056

  • Telephone

  • FAX

  • Chairman

    Narayan Singh Rathore

  • Managing Director

    Narayan Singh Rathore

  • Company Secretary

    Rakesh Vishnoi

  • Auditor

    V R S K & Co

  • Face Value

    1

  • Listing

    BSE

  • Registrar

    Universal Capital Sec. Pvt Ltd
    21 Shakil Niwas,
    Mahakali Caves Road,Andheri (E)
    Mumbai - Mumbai - 400 093

Deep Health AI India Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Deep Health AI 1.58 8.49 4.25 -31.60 11.41
Abbott India 26,107.90 7,217.19 6,929.05 34.36 43.78
Astrazeneca Phar 6,298.05 2,304.07 2,275.58 92.82 27.86
Glaxosmi. Pharma 2,515.65 3,932.76 3,790.20 40.19 58.17
Novartis India 1,813.30 393.10 354.33 45.79 15.94
Cipla 1,357.00 20,102.60 18,979.95 41.36 13.88
Bliss GVS Pharma 682.50 773.53 729.81 63.43 12.51
Amrutanjan Healt 493.40 520.13 502.55 26.43 24.16
Fermenta Biotec. 439.75 474.15 450.25 20.53 18.77
Guj. Themis Bio. 374.85 168.25 165.82 100.23 18.05
Ambalal Sarabhai 35.00 19.52 3.94 64.81 6.77